With my friend ⁦DBT-BIRAC⁩ colleague ⁦Dr Shirshendu Mukherjee⁩ at key India biotech institutes today including RCB and THSTI one of our partners with BioE conducting the human immunology of Corbevax in clinical testing, and with a first ed of my first book, Forgotten People

👇🏽Dr Shirshendu Mukherjee joins the fight against TB. #WorldTBDay #TBHaregaDeshJeetega #TBMuktBharat @TBDivision Ministry of Health

AIIMS starts Validation Study of Indigenous HPV Tests for Cervical Cancer Screening Worldwide, cervical cancer is the fourth most common cancer in women, causing one death every two minutes. In India, it is the second most common cancer in women. According to GLOBOCAN 2022, an

.Rajesh Gokhale Secretary Department of Biotechnology chaired research immersion programme group meeting to discuss the modalities to kick start the Doctoral programme i3C BRIC-RCB in Bio-Sciences which aims to training future-ready researchers & science technocrats to address global challenges

Nature Medicine published clinical trial results on GEMCOVAC-OM, a self-amplifying mRNA vaccine developed by Gennova with support from Mission COVID Suraksha, BIRAC, DBT. It is safe, well-tolerated, and significantly enhances immunity against the Omicron variant.

The accomplishment of the qHPV vaccine marks a major stride in the fight against cervical cancer. Let's continue to strive for healthier communities through efforts in immunization. #WorldImmunizationWeek Dr Jitendra Singh Rajesh Gokhale DBT-BIRAC

The furore about Covishield is quite surprising. Nothing new in terms of information and more importantly nothing in that information that should make us fearful of vaccines.

The i3c BRIC-RCB #PhDProgram Timeline is here. Do not miss the opportunity to learn and grow in the field of #Biotechnology Dr Jitendra Singh Rajesh Gokhale RCB DBT-THSTI BRIC-NCCS BRIC-NABI @DBT_ILS DBT-IBSD BRIC-NABI BRIC-NIAB DBT-RGCB

Yesterday marked Day 1 of the first residency of #WomenLeadershipinSTEM, a program designed to enhance gender equality in STEM leadership in India, launched jointly w/ Gates Grand Challenges & DBT-BIRAC! 20 women leaders participating in the program gathered as Dr Shirshendu Mukherjee &

Cabinet approves the BioE3 Policy! PMO India Dr Jitendra Singh Rajesh Gokhale BRIC-NIPGR BRIC-NII DBT-THSTI ICGEB, New Delhi RCB BRIC-NCCS iBRIC-inStem DSTIndia CSIR, India

Congratulations Department of Biotechnology Rajesh Gokhale and team. Life sciences in India can, when steered carefully, contribute through fundamental discoveries and application to sustainable development and a clean environment, to the growth of the industry. All the best going forward

Union Cabinet approves #BioE3Policy (Biotechnology for Economy, Environment and Employment) for “Fostering High-Performance Biomanufacturing” to set the path towards a green, clean, prosperous, and self-reliant Bharat. Dr Jitendra Singh Rajesh Gokhale PMO India

High Performance Biomanufacturing can fundamentally transform the global economy from today’s consumptive and unsustainable manufacturing paradigm to the one based on regenerative principles. Dr Jitendra Singh Rajesh Gokhale PMO India #BioE3Policy

Under the visionary leadership of Hon'ble Prime Minister Narendra Modi, Bharat has demonstrated strong economic growth & is poised to be amongst the global best in the next industrial revolution fueled by biomanufacturing. Dr Jitendra Singh Rajesh Gokhale PMO India #BioE3Policy

The #BIOE3Policy harnesses the potential of biotech engineering and digitalization to spark innovation, nurture skilled workforce and boost employment opportunities. Dr Jitendra Singh Rajesh Gokhale PMO India

My Article in Hindustan Times, August 26 issue: Building a bioeconomy to boost green growth. #DBT Read: hindustantimes.com/opinion/buildi…

#PeoplesFestivalofIndia is unique bringing together 100 deeptech and grassroot innovators .Hosted by #IIC,NewDelhi and organised by C-CAMP and #GIAN from 25th to 29th Nov 2024 Pre-event report by BioVoice News biovoicenews.com/delhi-to-host-… Dr. Taslimarif Saiyed anil gupta NITI Aayog

Beautiful

LIVE from #FEPharma2025: The Panel Discussion on The New Innovation Imperative: Towards Access, Impact & Excellence is underway! Experts are sharing key insights on driving impact and excellence in healthcare innovation. Stay tuned for key takeaways! #PharmaSummit #PharmaAwards

Addressing the YUGM Conclave. Our endeavour is to empower the youth with skills that make them self-reliant and position India as a global innovation hub. x.com/i/broadcasts/1…